The role of a 503B outsourcing facility has expanded significantly in recent years. What was once viewed primarily as a source of compounded preparations is now expected to support broader operational needs as medical clinics scale services, manage growing demand, and navigate increasingly complex regulatory and logistical environments. Read More >
ProRx Pharma is an FDA-registered 503B facility focused on providing essential compounded sterile and non-sterile preparations. The company compounds products and formulations for medical institutions, physician offices, and 503A pharmacies, with a specialization in producing high-quality products to ensure patients have access to the medications they need during critical shortages.
This post is related to:
